Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance
Publication date:
2020
Publisher version:
Citación:
Molecular cancer therapeutics, 19(4), p. 1018-1030 (2020); doi:10.1158/1535-7163.MCT-19-0789
Descripción física:
p. 1018-1030
ISSN:
Patrocinado por:
OSU Comprehensive Cancer Center Leukemia Tissue Bank Shared Resource [P30 CA016058]; Boehringer IngelheimBoehringer Ingelheim; Lauber Funds for Immunotherapy in AML [R01 CA159296]; Spanish grant of Instituto de Salud Carlos IIIInstituto de Salud Carlos III [PI19/01353]
Collections
- Artículos [37532]
Files in this item
Métricas
Compartir
